Global Life Sciences Solutions Operations UK Ltd (doing business as Cytiva)
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 15 Oct 2025 | Alexandr Hobza Cabinet member | Exchange of views on regulatory environment for Life Sciences Manufacturing sector | — |
| 15 Oct 2025 | Alexandr Hobza Cabinet member | Exchange of views on regulatory environment for Life Sciences Manufacturing sector | SRC |
| 14 Oct 2025 | Vita Jukne Cabinet member | Life science sector and PFAS | — |
| 14 Oct 2025 | Vita Jukne Cabinet member | Life science sector and PFAS | SRC |
| 01 Sept 2025 | Vilija Sysaite Cabinet member | International trade and REACH | — |
| 01 Sept 2025 | Vilija Sysaite Cabinet member | International trade and REACH | SRC |
| 01 Jul 2025 | Giulia Del Brenna Head of Unit | The specifics of life science-related upcoming initiatives, including the new Bioeconomy Strategy, the Biotech Act, and Life Science Strategy. | — |
| 01 Jul 2025 | Giulia Del Brenna Head of Unit | The specifics of life science-related upcoming initiatives, including the new Bioeconomy Strategy, the Biotech Act, and Life Science Strategy. | SRC |
| 08 May 2025 | Paulina Dejmek Hack Cabinet member | Life Science sector and EU environmental legislation | SRC |
| 08 May 2025 | Paulina Dejmek Hack Cabinet member | Life Science sector and EU environmental legislation | — |
| 22 Apr 2025 | Irene Norstedt Director | Exchange of views on the upcoming European Commission Communication on a ‘Strategy for European Life Sciences’ | — |
| 22 Apr 2025 | Irene Norstedt Director | Exchange of views on the upcoming European Commission Communication on a ‘Strategy for European Life Sciences’ | SRC |
Mission & Goals
Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. We have a rich heritage tracing back hundreds of years and are part of Danaher Corporation. Our customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services they need to work better, faster and safer, leading to better patient outcomes. As a trusted partner to customers that range in scale and scope, Cytiva brings efficiencies to research and manufacturing workflows, ensuring the development, manufacture and delivery of transformative medicines to patients.
EU Legislative Interests
Industrial Policy Strategy, Trade Policies, European Union Health Care Policies, Pharmaceuticals, Intellectual Property, Environment, Life Sciences Skills, Regulatory Policies, Pandemic Preparedness, Supply Chain, Sustainability, Biotechnology Policies, Chemical Policies.
Communication Activities
N/A
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Cytiva is member of the Life Sciences Manufacturing Association (LSMA), MedTech Europe, and EuropaBio.
Organisation Members
N/A
Connected Legislation